Aaron Wealth Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Aaron Wealth Advisors LLC
- $832 Million
- Q3 2024
A detailed history of Aaron Wealth Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aaron Wealth Advisors LLC holds 3,186 shares of VRTX stock, worth $1.3 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,186
Previous 2,941
8.33%
Holding current value
$1.3 Million
Previous $1.38 Million
7.47%
% of portfolio
0.18%
Previous 0.19%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,726Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.9 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.43 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.68 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.81 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.66 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...